# Relmada Therapeutics, Inc.: Form 8-K, filed Nov 8, 2018

- Company: [Relmada Therapeutics, Inc.](/companies/rlmd.md) (CIK 1553643)
- Form: 8-K
- Filed: 2018-11-08
- Accepted by EDGAR: Nov 8, 2018, 17:00 ET
- Period: 2018-11-02
- Accession: 0001213900-18-015176
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1553643/000121390018015176/f8k110218_relmadatherape.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1553643/000121390018015176/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1553643/000121390018015176/f8k110218_relmadatherape.htm

Filed Nov 8, 2018.
Source: SEC EDGAR, the filing index for accession 0001213900-18-015176. Last ingested by Listed: Nov 13, 2026, 15:42 ET. No prices; not investment advice.
